Walid Abi-Saab
Chief Tech/Sci/R&D Officer at UNIQURE N.V.
Net worth: 606 840 $ as of 2024-03-30
Profile
Dr. Walid Abi-Saab, MD, is a Chief Medical Officer at Galapagos NV. Dr. Abi-Saab was previously employed as a Group Vice President-Clinical Development by Shire Plc and an Assistant Professor-Psychiatry & Neurosurgery by Yale School of Medicine. He received his doctorate degree from the University of Saint Joseph (Macau).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UNIQURE N.V.
0.24% | 2024-02-29 | 116,700 ( 0.24% ) | 606 840 $ | 2024-03-30 |
Walid Abi-Saab active positions
| Companies | Position | Start |
|---|---|---|
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 2023-06-25 |
Former positions of Walid Abi-Saab
| Companies | Position | End |
|---|---|---|
| GALAPAGOS NV | Chief Tech/Sci/R&D Officer | 2022-12-30 |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| Yale School of Medicine | Corporate Officer/Principal | - |
Training of Walid Abi-Saab
| American University of Beirut | Undergraduate Degree |
| Université Saint-Joseph | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| UNIQURE N.V. | Health Technology |
| Private companies | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
- Stock Market
- Insiders
- Walid Abi-Saab
